banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4

Hims & Hers offers generic semaglutide as Novo Nordisk patent lapses

Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is a major opportunity to show what affordable, high-quality weight loss care can look like,” said Andrew Dudum, co-founder and CEO of Hims & … Read more

Why Hims & Hers turned to the autonomous vehicle industry to find an AI-savvy CTO

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief technology officer. The move, according to Hims & Hers co-founder and CEO, Andrew Dudum, was intentional. Hims & Hers on Thursday said its next CTO would be Mo Elshenawy, the former president and CTO … Read more

Hims & Hers Health: A Telehealth Powerhouse on the Rise

As of this writing, Hims & Hers Health Inc. (NYSE:HIMS) has seen a remarkable 25.74% surge in its stock price to $35.81, making it one of the top gainers in today’s market. This significant increase is largely attributed to the company’s recent partnership with Novo Nordisk to sell Wegovy, a weight-loss drug, on their telehealth … Read more

Hims & Hers shares plunge 28% on concerns over weight loss business

Shares of Hims & Hers Health fell 28% on Tuesday, a day after the telehealth company released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business. Hims & Hers reported $481 million in revenue for the quarter, up 95% from $246.6 million during the same period … Read more

Hims & Hers shares fall after FDA says semaglutide no longer in shortage

Products of Hims & Hers displayed. Hims & Hers Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk’s blockbuster weight loss drugs Wegovy and diabetes treatment Ozempic. Those … Read more

Hims & Hers Super Bowl ad promotes compounded GLP-1 drugs, which aren’t FDA-approved

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal InformationFORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive … Read more

Hims & Hers donates $1 million to Donald Trump’s inauguration fund

Hims & Hers Health has donated $1 million to President-elect Donald Trump’s inauguration fund, CNBC confirmed Tuesday. The company, which offers a range of direct-to-consumer treatments for conditions like weight loss, erectile dysfunction and hair loss, is the latest in a string of tech companies that have tried to curry favor with the incoming administration. … Read more

banner banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4